//
E Chronopoulou
S Shaikh
A Gaetano-Gil
C Raperport
K Tsiveriotis
B.H Al Wattar
J Zamora
P Bhide
General University Hospital of Patras, Obstetrics and Gynaecology- Fetal Medicine, Patras, Greece
Hospital Universitario Ramón y Cajal IRYCIS- Clinical Biostatistics Unit, Clinical Biostatistics, Madrid, Spain
Clinical Biostatistics Unit- Hospital Universitario Ramón y Cajal IRYCIS- CIBER Epidemiology and Public Health CIBERESP- Women's Health Research Unit- Queen Mary University of London, Clinical Biostatistics, Madrid, Spain
Institute for Womens Health- University College London- Women's Health Department- University College London Hospitals, Women's Health, London, United Kingdom
London North West University Healthcare NHS Trust- Queen Mary University of London, Obstetrics and Gynaecology, London, United Kingdom
Homerton University Hospital- Queen Mary University of London, Fertility and Assisted Reproduction, London, United Kingdom
CREATE Fertility, Fertility and Assisted Reproduction, London, United Kingdom
CRGH- The Centre for Reproductive & Genetic Health, Fertility and Assisted Reproduction, London, United Kingdom
Greece
Spain
United Kingdom
N/A
N/A
N/A
Human chorionic gonadotropin
Misoprostol
Cytotec
N/A
Randomized
Controlled
NA
N/A
N/A
N/A